Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Atezolizumab in Advanced Cutaneous Squamous Cell Carcinoma
NCT04710498Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jun 2021
- Primary completion
- Feb 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in cutaneous squamous cell carcinoma (cSCC), sponsored by Stanford University. Started Jun 2021; status: completed.
02
Drugs
atezolizumab
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT04710498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04710498.